Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miles Rush"'
Publikováno v:
BJPsych Open. 8:S128-S128
AimsDevelopment of an eating disorder in childhood has been shown to predict sleep disturbance in adulthood. Both the National Institute of Health and Care Excellence (NICE) and the wider scientific literature support interventions to help support pa
Autor:
Miles Rush, Doyle Coyne, Linnea I. Jansson, Joanne L. Bailey, Tilman Sanchez-Elsner, Andrew J. Wallace, Jeremy R. Sanford, Katrin Deinhardt, Rocio T. Martinez-Nunez, Sol Katzman, Hanane Ennajdaoui
Publikováno v:
Martinez Nunez, R T, Wallace, A, Coyne, D, Bailey, J, Jansson, L, Ennajdaoui, H, Rush, M, Deinhardt, K, Sanchez-Elsner, T & Sanford, J 2017, ' Modulation of nonsense mediated decay by rapamycin ', Nucleic Acids Research, vol. 45, no. 6, pp. 3448–3459 . https://doi.org/10.1093/nar/gkw1109
Nucleic acids research, vol 45, iss 6
Nucleic Acids Research
Nucleic acids research, vol 45, iss 6
Nucleic Acids Research
Rapamycin is a naturally occurring macrolide whose target is at the core of nutrient and stress regulation in a wide range of species. Despite well-established roles as an inhibitor of cap-dependent mRNA translation, relatively little is known about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afc9a69ee5f62e08d946dbfe3ad9625
https://kclpure.kcl.ac.uk/ws/files/114923923/Modulation_of_nonsense_mediated_NUNEZ_Accepted_28_October_2016_GOLD_VoR_CC_BY_.pdf
https://kclpure.kcl.ac.uk/ws/files/114923923/Modulation_of_nonsense_mediated_NUNEZ_Accepted_28_October_2016_GOLD_VoR_CC_BY_.pdf
Autor:
Rocio T. Martinez-Nunez, Hanane Ennajdaoui, Miles Rush, Linnea I. Jansson, Doyle Coyne, Tilman Sanchez-Elsner, Jeremy R. Sanford
RNA surveillance by the Nonsense Mediated Decay (NMD) pathway eliminates potentially deleterious transcripts containing Premature Termination Codons (PTCs). The transition from a pioneering round of translation to steady state translation is hypothes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56670c24a758b67e9f4ff71c34b6ea16
Autor:
Julia Wright, Louise Downey, Violeta Razanskaite, Simon Whiteoak, Kim Perry, Eren Efrem, Caron Underhill, Fraser Cummings, Miles Rush, Marion Bettey, Sarah Ker, Iftikar Ahmed, James Callaghan
Publikováno v:
Journal of Crohn's and Colitis. :jjw216
Background and aims Biosimilar infliximab CT-P13 offers the potential for large drug acquisition cost savings. However, there are limited published data regarding its efficacy, safety, and immunogenicity in inflammatory bowel disease [IBD], particula